Models, Models, Everywhere: But Which One Should Guide Care?
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Drekolias and colleagues report a therapy-specific prognostic model integrating mutational and cytogenetic features to risk-stratify survival in patients with acute myeloid leukemia treated with venetoclax-based regimens, providing a clinically relevant framework amid a rapidly expanding landscape of competing models. See related article by Drekolias et al., p. 403.
Fields of Study & Subjects
Acute Myeloid Leukemia Research
Retinoids in leukemia and cellular processes
Chronic Myeloid Leukemia Treatments
Publication details
- Journal / source
- Blood Cancer Discovery
- Volume
- 7
- Issue
- 3
- Pages
- 339–342
- Publication date
- 31 March 2026
- Language
- EN